Skip to content
Biodatica
Start free

Theralase® Technologies Inc.

Chicago, Illinois

OncologyPhase IIIListed · TLTFF

This company trades under its own ticker, so it sits outside Biodatica’s pre-ticker window. The record stays here because its filings are real, but the feed leaves listed companies out unless you ask for them.

Compare Sign in to watch

What changed

Phase II trial registered: Intravesical Photodynamic Therapy ("PDT") in BCG-Unresponsive/Intolerant Non-Muscle Invasive Bladder Cancer ("NMIBC") Patients

7mo agoTrial registeredNov 24, 2025Source filing (opens the source filing in a new tab)

Momentum

64no change

Momentum 64 out of 100, unchanged since the last recompute.

Some recent activity, at a steady rate.

Runway (estimate)

—unknown

No disclosed raise on file, so there is nothing to model from.

Stage

Phase III

The furthest-along thing in the public record. Not a projection.

Runway is an estimate: the last disclosed raise (SEC Form D) minus a modeled burn rate for the company’s stage and therapeutic area. It is not a disclosure, and companies routinely raise non-dilutive money we can’t see. How this is calculated.

Grant to raise

Every record Biodatica has resolved onto this company, newest first, each linked to the filing it came from. Where a source publishes no stable deep link for a record, the identifier is shown so you can look it up yourself.

  1. Trial

    PHASE3 registered

    Feb 8, 2021

    Bladder Cancer, Bladder Urothelial Carcinoma · RECRUITING · sponsor: University Health Network, Toronto · Neoadjuvant Upper Tract Invasive Cancer Trial (NAUTICAL)

    ClinicalTrials.gov · NCT04574960 (opens the source filing in a new tab)

  2. Trial

    PHASE2 registered

    Aug 30, 2019

    Non-Muscle Invasive Bladder Cancer ("NMIBC") Unresponsive/Intolerant to BCG · RECRUITING · sponsor: Theralase® Technologies Inc. · Intravesical Photodynamic Therapy ("PDT") in BCG-Unresponsive/Intolerant Non-Muscle Invasive Bladder Cancer ("NMIBC") Patients

    ClinicalTrials.gov · NCT03945162 (opens the source filing in a new tab)

Biodatica publishes impersonal research shown identically to every subscriber. This dossier is informational only, it is not investment advice, and the momentum and runway figures are estimates derived from public filings. The underlying records are U.S. government works. Disclosures · Data sources